Stockscreener 앱 받기
3.76
2.08%
-0.08
시장 영업 전:
3.85
0.09
+2.39%
전일 마감가:
$3.84
열려 있는:
$3.82
하루 거래량:
328.53K
Relative Volume:
0.20
시가총액:
$477.19M
수익:
$433.14M
순이익/손실:
$4.95M
주가수익비율:
105.32
EPS:
0.0357
순현금흐름:
$6.55M
1주 성능:
-3.59%
1개월 성능:
-10.69%
6개월 성능:
-18.53%
1년 성능:
+4.16%
1일 변동 폭
$3.66
$3.855
1주일 범위
$3.66
$3.98
52주 변동 폭
$2.6101
$7.0771
Organogenesis Holdings Inc Stock (ORGO) Company Profile
명칭
Organogenesis Holdings Inc
전화
781-575-0775
주소
85 DAN ROAD, CANTON, MA
Compare ORGO vs TAK, ZTS, HLN, TEVA, UTHR
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
ORGO
Organogenesis Holdings Inc
|
3.76 | 487.34M | 433.14M | 4.95M | 6.55M | 0.0357 |
|
TAK
Takeda Pharmaceutical Co Adr
|
18.28 | 57.18B | 29.85B | 776.90M | 4.35B | 0.2408 |
|
ZTS
Zoetis Inc
|
128.67 | 56.47B | 9.40B | 2.65B | 2.24B | 5.935 |
|
HLN
Haleon Plc Adr
|
11.16 | 49.16B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
34.31 | 40.03B | 17.41B | 1.43B | 1.00B | 1.2182 |
|
UTHR
United Therapeutics Corp
|
475.85 | 20.37B | 3.13B | 1.27B | 1.12B | 26.39 |
Organogenesis Holdings Inc Stock (ORGO) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-06-28 | 개시 | Lake Street | Buy |
| 2024-02-07 | 개시 | Cantor Fitzgerald | Overweight |
| 2023-06-15 | 개시 | Morgan Stanley | Equal-Weight |
| 2023-05-24 | 업그레이드 | BTIG Research | Neutral → Buy |
| 2022-11-10 | 다운그레이드 | BTIG Research | Buy → Neutral |
| 2022-08-10 | 다운그레이드 | Oppenheimer | Outperform → Perform |
| 2020-01-10 | 개시 | SVB Leerink | Outperform |
| 2019-08-26 | 재개 | Credit Suisse | Outperform |
| 2019-05-02 | 개시 | Credit Suisse | Outperform |
| 2019-04-17 | 개시 | Oppenheimer | Outperform |
| 2019-04-11 | 개시 | SunTrust | Buy |
모두보기
Organogenesis Holdings Inc 주식(ORGO)의 최신 뉴스
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Vizsla Silver Corp. - GlobeNewswire Inc.
Is Organogenesis Holdings Inc impacted by rising ratesWeekly Trade Summary & Long Hold Capital Preservation Tips - baoquankhu1.vn
Organogenesis Holdings Inc. (NASDAQ:ORGO) Looks Inexpensive After Falling 25% But Perhaps Not Attractive Enough - 富途牛牛
Treasury Yields: Why is Primoris Services Corporation stock going downAnalyst Downgrade & Growth Oriented Trade Recommendations - baoquankhu1.vn
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Organogenesis Holdings Inc.ORGO - Chartmill
Undervalued Opportunities: Penny Stocks To Watch In January 2026 - simplywall.st
The Truth About Organogenesis Holdings (ORGO): Quiet Biotech Sleeper Stock or Total Trap? - AD HOC NEWS
Is Organogenesis Holdings (NASDAQ:ORGO) In A Good Position To Deliver On Growth Plans? - Yahoo Finance
Analysis Recap: Is Organogenesis Holdings Inc backed by strong institutional buyingJuly 2025 Final Week & Real-Time Stock Movement Alerts - baoquankhu1.vn
Aug Macro: Is Organogenesis Holdings Inc a strong growth stockJuly 2025 Action & Accurate Intraday Trade Tips - baoquankhu1.vn
About Us - FinancialContent
The Market Doesn't Like What It Sees From Organogenesis Holdings Inc.'s (NASDAQ:ORGO) Revenues Yet As Shares Tumble 28% - simplywall.st
Hedge Fund Bets: Is Organogenesis Holdings Inc benefiting from innovation trendsDay Trade & AI Optimized Trading Strategy Guides - baoquankhu1.vn
Pomerantz Law Firm Investigates Claims On Behalf of Investors of Organogenesis Holdings Inc.ORGO - FinancialContent
Europe Advanced Wound Care Market Size, Share Projections 2032 - openPR.com
Published on: 2026-01-13 05:15:38 - baoquankhu1.vn
Is Organogenesis Holdings (NASDAQ:ORGO) In A Good Position To Invest In Growth? - Sahm
Organogenesis drops as Medicare to pull skin substitute LCDs (update) - MSN
Is Organogenesis Holdings Inc. (2PQ) stock protected from inflationJuly 2025 Action & Free Technical Pattern Based Buy Signals - Улправда
Is Organogenesis Holdings Inc. stock a buy in volatile markets2025 Top Decliners & Growth Oriented Trade Recommendations - Улправда
What margin trends mean for Organogenesis Holdings Inc. stockIPO Watch & Pattern Based Trade Signal System - Улправда
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Organogenesis ... - Bluefield Daily Telegraph
News - FinancialContent
ORGOOrganogenesis Hldgs Inc Latest Stock News & Market Updates - Stock Titan
Three rising investors just landed bigger roles at a healthcare PE firm - Stock Titan
Organogenesis (NASDAQ:ORGO) Trading Down 5% – Time to Sell? - Defense World
Organogenesis (NASDAQ:ORGO) Shares Down 5%Here's What Happened - MarketBeat
Organogenesis Holdings Inc. (ORGO) Stock Analysis: Exploring 64% Potential Upside Amidst Strong Revenue Growth - DirectorsTalk Interviews
Organogenesis Holdings extends leases for Canton facilities through 2032 By Investing.com - Investing.com Australia
Organogenesis Holdings extends leases for Canton facilities through 2032 - Investing.com
Organogenesis Extends Long-Term Leases for Key Facilities - TipRanks
Organogenesis (NASDAQ:ORGO) Shares Gap DownTime to Sell? - MarketBeat
Organogenesis' (ORGO) "Buy" Rating Reiterated at BTIG Research - MarketBeat
Organogenesis stock holds Buy rating at BTIG after CMS LCD decision - Investing.com Australia
Organogenesis stock holds Buy rating at BTIG after CMS LCD decision By Investing.com - Investing.com South Africa
Organogenesis Announces Initiation of Biologics License Application for ReNu® - The Manila Times
Organogenesis Initiates BLA Submission For ReNu In Knee Arthritis - Nasdaq
Organogenesis begins FDA rolling review for knee arthritis treatment By Investing.com - Investing.com Nigeria
Organogenesis starts rolling submission for ReNu allograft for knee arthritis - Seeking Alpha
Organogenesis stock rises after initiating FDA application for knee arthritis treatment By Investing.com - Investing.com South Africa
Organogenesis stock rises after initiating FDA application for knee arthritis treatment - Investing.com Nigeria
Organogenesis Holdings Inc (ORGO) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.21%
0.15%
자본화:
|
볼륨(24시간):